Showing results (281-290 of 331) with videos related to
Sort By:
Pageof 34
Experimental Hematology & Oncology|August 5, 2024
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatmentSilvia Vanni, Giacomo Miserocchi, Graziana Gallo, et al.Gastrointestinal Tumors|November 27, 2019
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation CohortAndrea Casadei-Gardini, Leonardo Solaini, Laura Riggi, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 5, 2014
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutationsMaria A Pantaleo, Cristian Lolli, Margherita Nannini, et al.European Journal of Cancer (Oxford, England : 1990)|October 7, 2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationaleAndrea Casadei Gardini, Luca Faloppi, Serena De Matteis, et al.Annals of Transplantation|November 14, 2018
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin ProphylaxisSusanne Beckebaum, Kerstin Herzer, Artur Bauhofer, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 3, 2024
Pre-operative evaluation of spontaneous portosystemic shunts as a predictor of post-hepatectomy liver failure in patients undergoing liver resection for hepatocellular carcinomaGianluca Rompianesi, Ho-Seong Han, Giuseppe Fusai, et al.Updates in Surgery|May 3, 2025
Short-term outcomes of minimally invasive gastrectomy in population with obesity versus population without obesity: the obesity paradoxMarco Milone, Anna D'Amore, Gian Luca Baiocchi, et al.Lancet (London, England)|November 23, 2025
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trialMichele Reni, Marina Macchini, Giulia Orsi, et al.Transplantation|March 30, 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter StudyPaolo De Simone, Renato Romagnoli, Francesco Tandoi, et al.Annals of Surgical Oncology|June 28, 2017
The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin MicrospheresFernando Pardo, Bruno Sangro, Rheun-Chuan Lee, et al.Pageof 34